Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with a median
survival of 3–4 years from time of initial diagnosis, similar to the time course of many …

Idiopathic pulmonary fibrosis (IPF) is a chronic disease with an unknown etiology that
causes deterioration of the structure of the lung parenchyma, resulting in a severe and …

Idiopathic pulmonary fibrosis (IPF) is a progressive, life-threatening interstitial lung disease
of unknown aetiology and with limited proven treatment options. As it is predominately a …

Despite several advances in treatment, idiopathic pulmonary fibrosis (IPF) remains a
progressive, symptomatic, and terminal disease in patients not suitable for lung …

Background Idiopathic pulmonary fibrosis (IPF) is a fatal disease that results in poor quality
of life due to progressive respiratory symptoms, anxiety, and depression. Palliative care …

Context Although idiopathic pulmonary fibrosis (IPF) has worse outcomes compared with
most malignancies, patients with IPF receive poor access to optimal palliative care …

Symptom burden plagues patients with progressive fibrotic interstitial lung disease (PF-
ILD)[1]; this symptom burden, in combination with poor prognosis and uncertainty of disease …

Background: Early and integrated palliative care is recommended for patients with idiopathic
pulmonary fibrosis. Unfortunately, palliative care delivery remains poor due to various …

Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pneumonia
characterized by progressive fibrosis. Chronic refractory breathlessness is the clinical …

The article discusses a study conducted by Claudia Ravaglia and colleagues on palliative
medicine and the quality of care in the last days of patients suffering from Idiopathic …